Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Brandon Slover
Observed name:
B. Slover
Institutions:
Battelle,
University of Kentucky,
George Washington University,
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University Wexner Medical Center,
The Ohio State University
show all 6
Observed institutions:
Battelle,
University of Kentucky,
George Washington University,
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University Wexner Medical Center,
The Ohio State University
show all 6
ORCID:
0009-0000-2136-1567
Observed ORCID:
0009-0000-2136-1567
OpenAlex ID:
A5116840401
Area-specific autoencoder spatiotemporal graph neural networks for opioid overdose death prediction
2026
·
Xianhui Chen
, Changchang Yin
, et al.
·
JAMIA Open
·
1
Chemotherapy use among women < 50 years with node-negative early-stage hormone receptor–positive breast cancer with intermediate OncotypeDX 21-gene recurrence score: A National Cancer Database analysis.
2026
·
Nerea Lopetegui-Lia
, Yevgeniya Gokun
, et al.
·
Journal of Clinical Oncology
Sociodemographic and clinical characteristics of women < 50 years and impact on adjuvant chemotherapy decisions across OncotypeDX RS or unknown OncotypeDX categories. A National Cancer Database (NCDB) analysis.
2026
·
Nerea Lopetegui-Lia
, Yevgeniya Gokun
, et al.
·
Journal of Clinical Oncology
Clinical-genomic discordance and chemotherapy (CT) outcomes in early-stage HR+/HER2– invasive lobular carcinoma.
2026
·
Arya Mariam Roy
, Yevgeniya Gokun
, et al.
·
Journal of Clinical Oncology
PDF
Chemotherapy use among women < 50 years with hormone receptor–positive breast cancer with low (≤15) Oncotype DX 21-gene recurrence score: A National Cancer Database (NCDB) analysis.
2026
·
Mitali Shah
, Yevgeniya Gokun
, et al.
·
Journal of Clinical Oncology
Adjuvant chemotherapy (CT) benefit in invasive lobular carcinoma (ILC) by Oncotype DX Recurrence Score and menopausal status.
2026
·
Arya Mariam Roy
, Yevgeniya Gokun
, et al.
·
Journal of Clinical Oncology
ASO Visual Abstract: Receipt of Combined Axillary Dissection and Nodal Irradiation Varies by Age
2026
·
Sara P. Myers
, Yevgeniya Gokun
, et al.
·
Annals of Surgical Oncology
Receipt of Combined Axillary Dissection and Nodal Irradiation Varies by Age
2026
·
Sara P. Myers
, Yevgeniya Gokun
, et al.
·
Annals of Surgical Oncology
PDF
The Ties That Bind: The Relationships Among Members in Nine Ohio HEALing Communities Coalitions
2026
·
Jill Davis
, Pamela Salsberry
, et al.
·
Journal of Public Health Management and Practice
Radiation treatment patterns for breast cancer brain metastases: an NCDB analysis
2026
·
Thamilini Pathmarajah
, Yevgeniya Gokun
, et al.
·
Breast Cancer Research and Treatment
PDF
Abstract 6646: Impact of histology subtypes (ductal, lobular, and mixed ductal/lobular) on pathological complete response (pCR) following neoadjuvant chemotherapy (NAC) and chemoimmunotherapy (NACI) for estrogen receptor low (ER-low) HER2-negative breast cancer.
2026
·
Kai C. Johnson
, Brandon Slover
, et al.
·
Cancer Research
Abstract PS4-08-04: Impact of adjuvant chemotherapy in the survival outcomes of early-stage hormone receptor (HR)-positive HER2-negative lobular versus ductal carcinoma patients
2026
·
A. Roy
, Y. Gokun
, et al.
·
Clinical Cancer Research
Abstract PS2-02-06: Benefit of adjuvant chemotherapy for early-stage hormone receptor positive and HER2 negative lobular breast cancer patients: Analysis based on genomic risk scores
2026
·
A. Roy
, Y. Gokun
, et al.
·
Clinical Cancer Research
Abstract PS2-02-26: Treatment patterns and prognosis of patients with HER2-negative early breast cancer and germline pathogenic variants in BRCA1, BRCA2, ATM, CHEK2 and PALB2
2026
·
V. Prasath
, A. N. Riner
, et al.
·
Clinical Cancer Research
Abstract PS2-09-22: The Impact of Breast Cancer Histology and Tumor Molecular Subtype on Nodal Positivity
2026
·
S. Myers
, Y. Gokun
, et al.
·
Clinical Cancer Research
Disparities in Radiation Treatment of Breast Cancer Brain Metastases
2025
·
T. Pathmarajah
, Y. Gokun
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Survival impact of adjuvant chemotherapy regimens for small (T1mi/a/b), node-negative (pN0), triple-negative breast cancer (TNBC).
2025
·
Kai Conrad Cecil Johnson
, Joanne Kim
, et al.
·
Journal of Clinical Oncology
HSR25-154: Treatment Patterns and Prognosis of Patients With HER2-Negative Early Breast Cancer and Germline Pathogenic Variants in BRCA1, BRCA2, ATM, CHEK2 and PALB2
2025
·
Vishnu Prasath
, Andrea Riner
, et al.
·
Journal of the National Comprehensive Cancer Network
Show more works
View as search
Works count:
18
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type